Avhandlingar
2025
- Immune Response in Triple-Negative Breast Cancer-Machine Learning-based Insights from Histology and-Omics, Suze Roostee - 25 feb 2025
2024
- Selenoproteins as predictors of prognosis after breast cancer diagnosis, Kamil Demircan - 29 nov 2024
- Regulation of estrogen receptor alpha by promoter methylation, alternative splicing and microRNA, Juliane Albrecht - 23 okt 2024
- Metabolic and angiogenic biomarkers in breast cancer: potential clinical implications of host–tumor interactions, Christopher Godina - 18 jun 2024
- Decoding pan-cancer complexity. Multiomic insights from the lung and breast, Deborah Figueiredo Nacer de Oliveira - 18 jun 2024
- Precision Medicine in Breast Cancer: A Molecular Genomics and Diagnostics Approach, Heena Dalal - 17 jun 2024
- Gene fusions and microRNAs in cancer, Völundur Hafstað - 13 jun 2024
- Aspects of breast-conserving surgery, Kim Gulis - 22 mar 2024
2021
- RNA sequencing for molecular diagnostics in breast cancer, Christian Brüffer - 13 jan 2017
2018
- Predictors of lymph node metastasis in primary breast cancer - risk models for tailored axillary management, Looket Dihge 27 april 2018
2017
- Treatment of BRCA 1/2-associated breast cancer and identification of mutation carriers among breast cancer patients, Martin Nilsson - 15 jun 2017